C

Cortexyme, Inc.

40 employees

Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2012

Funding rounds raised

Total raised

$125M

from 13 investors over 13 rounds

C

Cortexyme, Inc. raised $125M on December 13, 2019

Investors: KG Investments, LLC

C

Cortexyme, Inc. raised $76M on May 31, 2018

Investors: Dolby Family Ventures, Vulcan Capital, EPIQ, Verily and Takeda UK Limited

C

Cortexyme, Inc. raised $8M on April 14, 2017

Investors: Dolby Family Ventures, Takeda UK Limited and Breakout Ventures

C

Cortexyme, Inc. raised $15M on January 6, 2016

Investors: Dolby Family Ventures and Takeda UK Limited

C

Cortexyme, Inc. raised $1M on October 6, 2014

Investors: Dolby Family Ventures

C

Cortexyme, Inc. raised undisclosed on June 12, 2014

Investors: Breakout Labs

FAQ